Amber Medical For Profit
![](/files/companies/Amber%20Medical.png)
Scientific Breakthrough: Long-term prevention of thrombosis without DAPT! Each year, millions of patients worldwide undergo coronary stenting to treat ischemic heart disease. While drug-eluting stents, in comparison with bare-metal stents, reduce the rate of restenosis, there is concern that they are associated with a risk, starting one year after treatment, of stent thrombosis – a …
Founded Date:
2016-06-01
Estimated Revenue:
$3 million
Industry:
PharmTech
Technology:
Drug delivery
Headquarters:
Jerusalem, Yerushalayim, Israel